Menu
Back to Archived Journals » Hypoxia » Volume 5
Original Research
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,523 | Dovepress* | 8,216+ | 799 | 9,015 | |
| PubMed Central* | 307 | 104 | 411 | ||
| Totals | 8,523 | 903 | 9,426 | ||
| *Since 23 May 2017 | |||||
View citations on PubMed Central and Google Scholar